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A Woman with Recent Jaundice and Pruritus
Bita Behnava*, Seyed Moayed Alavian
Baqiyatallah Research Center for Gastroenterology and Liver Disease, Baqiyatallah University of Medical Sciences, Tehran, I.R. Iran
Case Presentation
A 41-old-woman suffering from jaundice, pruritus 
and  fatigue  which  had  begun  6  days  previously, 
presented herself to her general practitioner (GP). 
She did not have any fever, nausea, diarrhea, anorexia, 
abdominal  pain,  rash,  respiratory  symptoms  or 
arthralgia. She had lost five kilograms of weight over 
the preceding two months. At the time she visited 
her GP, her weight was 49 kg and her height 159 
cm. The patient did not have any history of blood 
transfusions or alcohol use. She had traveled to a 
rural area in northern Iran two months previously. 
Her  family  history  was  negative  for  liver  disease. 
For the preceding three months she had been taking 
chlordiazepoxide  without  a  prescription.  For  the 
past five months, she had been taking a weekly dose 
of three glasses of orange flower water as a herbal 
remedy.
Laboratory  analysis  showed  a  white  blood 
cell (WBC) count of 9100/µL of which 70% was 
neutrophil,  23%  lymphocyte,  6%  eosinophil  and 
1% monocyte. The alanine aminotransferase (ALT) 
level was 69 IU/ml (normal range 10 to 40), the 
aspartate  aminotransferase  (AST)  level  61  IU/ml 
(normal range 15 to 40), the alkaline phosphatase 
(ALP) level 525 IU/ml (normal range 45 to 150), the 
gamma-glutamyl transferase (GGT) level 410 IU/ml 
(normal range 10 to 80), the total bilirubin level 10 
mg/dl(normal range:0.3 to 1.3), the direct bilirubin 
level 8.7(normal range:0.1 to 0.3), amylase level 70 
IU/ml (normal range), albumin level 4 g/l, gamma 
glubolin 1.6 g/l, prothrombin time 12 second, INR 
1.1 and first hour ESR 20. Seromic IgG and IgM 
levels were normal. Serologic tests for hepatitis B 
virus (HBV), hepatitis C virus (HCV) and hepatitis A 
virus (HAV), human immunodeficiency virus (HIV) 
and also anti mitocondrial antibodies, anti smooth 
muscle antibodies and anti liver kidney microsomal 
antibodies  were  negative.  Anti  nuclear  antibodies 
wereat  a  very  low  positive  level.  Abdominal 
sonographic findings were normal and there was no 
dilation or obstruction of the biliary ducts.
Ten days later, the patient returred to the clinic 
with nausea, vomiting and worsening jaundice and 
pruritus. She was referred to a hospital for further 
evaluation. On admission, the patient was agitated and 
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A middle-aged woman suffering from jaundice and pruritus that had begun a month previously was presented to a phy-
sician. At the first assessment, laboratory findings had revealed a cholestatic pattern and serologic tests for hepatitis B 
virus (HBV), hepatitis C virus (HCV) and hepatitis A virus (HAV) were negative. Normal findings of abdominal computed 
tomography (CT) scan and endoscopic retrograde cholangiopancreatography (ERCP) ruled out extrahepatic causes of 
cholestasis. A liver biopsy was done and showed intrahepatic cholestasis without destruction of the bile ducts or granulo-
ma. We assessed the intrahepatic causes of cholestasis. Finally the diagnosis was confirmed by means of a simple test. 
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suffering from severe jaundice, nausea and pruritus. 
Her temperature was 37.6 C, her pulse 115 beats per 
minute, her blood pressure 130/80 mmHg and her 
respiratory rate 18 per minute. The patient had mild 
tenderness on right upper quadrant (RUQ) and her 
skin was moist; the remainder of the examination 
was normal. The results of laboratory tests revealed 
an ALT level 70 IU/mL, an AST level 61 IU/mL, 
an ALP level 590 IU/mL,GGT 389 IU/mL, a total 
bilirubin level 28 mg/dl, bilirubin direct 23.6mg/dl, 
angiotensine converting enzyme 65 IU/mL (normal 
range).  A  chest  x  ray  and  computed  tomography 
(CT) scan of the abdoman and pelvis showed no 
abnormalities. Serologic tests for Epstein-Barr virus 
(EBV),  cytomegalovirus  (CMV),  hepatitis  E  virus 
(HEV), brucella and fasciola hepatica were negative. 
Endoscopic  retrograde  cholangiopancreatography 
(ERCP) did not show any abnormality. A liver biopsy 
was done and revealed bile plugs in the canaliculi, 
pigment accumulation in the cytoplasm of some of 
the hepatocytes, an increase in Kupffer cells with 
pigment deposition in the perisinusoidal space, and a 
regular appearance of bile ductules, compatible with 
intrahepatic cholestasis (canalicular cholestasis). 
In view of her tachycardia, moist skin, agitation, 
hand  tremor  and  unknown  cholestasis,  thyroid 
function  tests  were  obtained.  Serum  thyroid 
hormone levels were: free thyroxine (FT4) 6.17 ng/
dl  (normal  range:  0.8–1.9);  free  triiodothyronine 
(FT3) 10.2 ng/dl (normal range: 1.8–4.2); thyroid-
stimulating hormone (TSH) less than 0.01 mU/ml 
(normal range: 0.4–4); and anti-thyroid peroxidase 
399(normal  range:  0-35).  Thyroid  scintigraphy  (3 
mCi Tc 99 m pertechnetate IV) indicated a diffuse 
high-level technetium uptake.
She  was  diagnosed  with  Graves’  disease. 
Propylthiouracil (PTU) was started at a daily dose 
of 300 mg. After five days of therapy, pruritus and 
jaundice had worsened (total bilirubin had increased 
to 31mg/dL and her ALP to 670 IU/ml) so PTU was 
stopped and radioactive iodine (I131) was initiated 
for  thyroid  ablation.  Nausea  and  pruritus  were 
eliminated after one week and jaundice improved 




The initial presentation of the patient suggested 
possible  diagnoses  of  viral  hepatitis,  alcoholic 
hepatitis, hepatotoxic drugs or remedies, autoimmune 
hepatitis or cholestatic syndrome. Serologic tests for 
hepatotropic  viruses  were  negative.  On  the  basis 
of history, alcoholic hepatitis could be ruled out. 
Chlordizepoxide  has  no  hepatotoxic  side  effects 
and also orange flower water was unlikely to be a 
cause for her disease. The levels of gamma globulin, 
Immunoglobulin G (IgG) and Immunoglobulin M 
(IgM)  were  normal  and  also  autoantibodies  were 
negative; thus a diagnosis of autoimmune hepattitis 
was unlikely. The pattern of elevated liver enzymes, 
alkaline phosphatase and bilirubin was consistent with 
a cholestasis possibly due to intra- and extrahepatic 
causes.  Sonography  of  her  right  upper  quadrant 
did not show any extrahepatic obstruction. Despite 
the high degree of sensitivity and specficity of this 
imaging  technique,  some  causes  of  obstruction 
may be missed. As the next step for evaluation of 
probable extahepatic cholestasis, a CT scan and an 
ERCP were done. We discuss the causes of extra-
and intrahepatic cholestasis in this case. 
Extra-hepatic causes
Choledocholithiasis:  In  a  41-year-old  woman 
with a cholestatic presentation, choledocholithiasis as 
the most common cause of extrahepatic cholestasis 
should  be  considered.  It  can  cause  a  range  of 
symptoms from mild right upper quadrant pain with 
only  minimal  elevations  of  alkaline  phosphatase, 
to jaundice and fever due to ascending cholangitis. 
However, gall bladder sonography and ERCP did 
not show any stones. 
Malignancies: Cholestatic jandice and significant 
weight loss (nearly 10% of total weight) in the present 
case would suggest the probability of malignancies. 
Tumors  of  the  pancreas,  gallbladder,  ampullary, 
cholangiocarcinoma  and  portal  adenopathy  can 
cause extrahepatic cholestasis. However, in this case 
the normal findings of abdominal sonography, a CT 
scan and an ERCP ruled out these causes.
Fasciola hepatica: The patient had travelled to 
a village in northern Iran and eaten fresh vegetables 
two months before the onset of her disease and 
also had had a mild eosinophilia in the peripheral 
blood smear. Cholestatic hepatitis and eosiniphilia in 
a patient with a history of travelling to an endemic 
region for fasciola hepatica should be suspected in 
forming this diagnosis. Fascioliasis was divided into 
two phases: in the liver phase, the larvae migrate 
through the liver tissue, there is pain in right upper 
quadrant,  and  fever  and  sometimes  jaundice  may 
occur.  In  the  biliary  phase,  the  adult  flukes  may 
obstruct the common duct and is associated with 
cholestatic jaundice (1, 2). Eosinophilia is a variable 
finding  in  this  phase  of  the  disease.  However, 
serologic testing for fasciola hepatica was negative 
and ultrasound and ERCP findings were normal.
Pancreatitis:  One  of  the  complications  of 
chronic  pancreatitis  is  bile  duct  stricture  and Hepatitis Monthly, Winter 2010; 10(1): 48-52
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cholestatic jaundice (3). This is most commonly seen 
in patients with a long history of epigastric pain and 
pancreatic insufficiency, but she did not have such 
a history and also her serum amylase level and the 
ERCP findings were normal. In view of the normal 
CT scan and ERCP findings, extrahepatic causes of 
cholestasis were unlikely. However the intrahepatic 
causes remain as a major diagnosis. A liver biopsy was 
done to determine the etiology of her disease and 
was consistent with an acute canalicular cholestasis 
without ductopenia.
Intrahepatic causes
Viral infections: Many of the virus infections 
that  typically  cause  a  hepatocellular  pattern  of 
injury can also present as a cholestatic feature such 
as HAV, HEV, EBV, CMV (4-8). Hepatitis A can be 
followed by a prolonged cholestasis that may last 8 
to 12 weeks and is usually characterized by severe 
jaundice(with a total bilirubin of more than 10mg/
dL, a marked elevation of ALP and a mild elevation 
of  aminotrasferases),  pruritus,  fever,  weight  loss, 
diarrhea,  and  malaise  (9).  Also,  a  few  cases  of 
cholestasis have been reported in patients with HEV 
infection (10). One of the clinical manifestations of 
CMV  and  EBV infections is hepatitis, which can 
occur in patients with febrile syndrome. In some of 
these patients,a cholestatic feature may predominate 
(5, 6), although the patient did not have fever and 
her serologic tests for all of these infections were 
negative. 
A cholestatic feature in HBV and HCV infections 
(fibrosing  cholestatic  hepatitis)  may  present  after 
solid organ transplantation (11-13). 
Drugs and herbal remedies: Several drugs can 
cause intrahepatic cholestasis, including amitriptyline, 
ampicillin,  amoxicillin-clavulanate,  carbamazepine, 
chlorpromazine,  cyproheptadine,  erythromycin 
estolate, haloperidol, imipramine, prochlorperazine, 
phenytoin,  trimethoprim-sulfamethoxazole, 
tetracycline  and  atorvastatin  (14-18).  The  patient 
had used chlordiazepoxide for anxiety, but it does 
not  seem  that  this  drug  could  cause  cholestasis. 
Herbal remedies should be considered as a cause of 
unknown cholestatic hepatitis. Several case reports 
have shown the association between some of the 
natural remedies such as senna and Cascara sagrada 
and cholestatic hepatitis (19). The patient had used 
orange  flower  water  for  five  months,  but  it  does 
not  appear  to  cause  cholestatic  hepatitis.  PTU  is 
listed among the drugs that can cause intrahepatic 
cholestasis (20-22). After using PTU as an antithyroid 
therapy in this patient, her jaundice was aggravated.
Primary  sclerosing  cholangitis  (PSC):  PSC 
is characterized by the destruction and fibrosis of 
the intrahepatic and/or extrahepatic bile ducts. The 
majority  of  patients  with  this  condition  are  male 
and have underlying ulcerative colitis (23, 24). Fatigue 
and pruritus are common features at presentation, 
but  persistent  jaundice  usually  heralds  advanced 
disease. Hypergammaglobulinemia, increased serum 
IgM  levels  and  atypical  perinuclear  antineutrophil 
cytoplasmic antibodies (P-ANCA) may be seen in 
these  patients.  ERCP  findings  include  multifocal 
stricturing  and  dilation  of  intrahepatic  and/or 
extrahepatic bile ducts. However in this case, ERCP 
findings were normal. 
Primary  biliary  cirrhosis:    Primary  biliary 
cirrhosis  (PBC)  is  characterized  by  a  progressive 
autoimmune  destruction  of  small  intralobular 
bile  ducts  and  finally  results  in  cirrhosis  and 
liver  failure  (25).  It  typically  presents  in  middle-
aged  women.  Fatigue  and  pruritus  are  the  most 
common presenting symptoms of PBC. Like PSC, 
jaundice is most often a late symptom that reflects 
advanced liver disease (25). It should be noted that in 
prolonged intrahepatic cholestasis with jaundice,the 
presence  of  signs  of  advanced  liver  disease 
suggests  PBC,  PSC  or  overlapping  syndromes. 
Hyperpigmentation,  hepatosplenomegaly 
and  osteopenia  can  be  seen  in  these  patients. 
The  finding  of  antimitochondrial  antibodies 
(AMA)  seropositivity  is  highly  sensitive  (95%  to 
98%) as a diagnostic test. Nevertheless, the diagnosis 
of PBC should be confirmed by liver biopsy. The 
early  stages  of  PBC  are  characterized  by  portal 
hepatitis, granulomas and bile duct lesions, but in 
progressive stages fibrosis spanning portal tracts and 
ductopenia are dominated (26). The cholestatic feature 
in the present case was not followed by any signs 
of advanced liver disease. Also her AMA test was 
negative and her liver histological features showed 
an intrahepatic cholestasis without any bile ductule 
lesions or granulomas which is not compatible with 
primary biliary cirrhosis. 
Autoimmune  cholangitis:  Autoimmune 
cholangitis is typically found in groups of patients 
who  have  histologic  features  suggesting  PBC  but 
are often seronegative for AMA, and generally have 
circulating  antinuclear  antibodies  (ANA)  and/or 
smooth muscle antibodies (SMA) (27). We considered 
the  probability  of  autoimmune  cholangiopathy  in 
a  middle  aged  woman  with  unknown  cholestasis, 
autoimmune  hyperthyroidism  who  tested  positive 
for ANA, but the patient had a very low level of anti 
nuclear antibodies in her serum and normal levels 
of IgG and IgM, and also the histologic findings 
were  not  consistent  with  PBC  or  autoimmune 
choangiopathy. 
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granulomatous  disorder  and  is  characterized  by 
noncaseating  granulomas  in  involved  organs. 
Hepatic  involvement  is  most  often  asymptomatic 
(only elevation of alkaline phosphatase and gamma 
glutamyl transpeptidase) but rarely cholestasis and 
cirrhosis can occur (28, 29). In the present case, the 
absence  of  clinical  signs  of  the  disease  in  other 
organs, a normal chest x ray, a normal ACE level and 
histologic findings (intrahepatic cholestasis without 
granulomas) would exclude sarcoidosis.
Stauffer's  syndrome:  This  paraneoplastic 
syndrome is a reversible intrahepatic cholestasis, in 
the absence of liver metastases. Stauffer’s syndrome is 
most commonly associated with renal cell carcinoma 
and less common with malignant lymphoproliferative 
disease  and  gynecologic  malignancies  (30).  In  this 
case, however, the CT scan of abdomen and pelvis 
was normal. 
Hyperthyroidism
At first visit the physician did not consider the 
signs of hyperthyroidism, but when the patient was 
hospitalized,  in  view  of  the  patient’s  tachycardia, 
moist  skin,  agitation,  hand  tremor  and  unknown 
intrahepatic  cholestasis,  thyroid  function  tests 
were  ordered.  Hyperthyroidism  with  high  level 
anti-thyroid  peroxidase  and  diffusely  uptake  on 
thyroid  scan  confirmed  the  diagnosis  of  Graves’ 
disease.  It  seems  that  her  intrahepatic  cholestatic 
jaundice had developed secondarily to autoimmune 
hyperthyroidism in the absence of congestive heart 
failure and was worsened by PTU. It was confirmed 
that when euthyroidism occurred, her jaundice was 
cured.  Thyroid  disorders  can  cause  abnormalities 
in  aminotransferases  and  alkaline  phosphatase 
levels.  Hyperthyroidism  can  rarely  be  associated 
with intrahepatic cholestasis (31-34). The underlying 
mechanisms  were  unclear,  but  some  hypotheses 
have explained the probable etiology of liver enzyme 
abnormalities  and  cholestasis  in  hyperthyroidism 
patients.  One  of  these  hypotheses,  has  suggested 
that in the absence of heart failure, hypoxia due to a 
hypermetabolic state can damage centrilobular zones 
and result to canalicular cholestasis (32, 33). In one 
study on rats, liver dysfuntion in hyperthyroidism 
has  been  attributed  to  mitochondrial  dysfunction 
(35).  Antithyroid  drugs  including  methimazole  or 
PTU can also induce or contribute to the cholestatic 
jaundice (32, 36, 37). It should be noted that cholestatic 
jaundice is a rare complication of hyperthyroidism 
and if it does occur the probability of heart failure, 
concomitant  with  autoimmune  hepatitis  or  other 
underlying  liver  disease  and  drug  hepatotoxicity 
should be considered. 
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